# DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

> **NCT00116116** · PHASE4 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 70 (—)

## Conditions studied

- HIV Infections
- AIDS

## Interventions

- **DRUG:** efavirenz, stavudine extended release, lamivudine

## Key facts

- **NCT ID:** NCT00116116
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 70 (—)
- **Last updated:** 2011-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00116116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00116116, "DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00116116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*